Direct Load Capture Cap Collection Kit

Transform specimen processing with the only nasopharyngeal (NP) swab that loads directly for COVID testing

 

No specimen transfer. Expedite your SARS-CoV-2* workflow with a collection device that loads directly on the Panther® system.  The Direct Load Capture Cap Collection Kit is authorized for use with the Aptima® SARS-CoV-2 and Aptima® SARS-CoV-2/Flu assays. 

 

Two-Step Workflow — Deliver Results Sooner

 

Traditional Respiratory Specimen Workflow

 

Reduce Labor, Costs and Risk with Fewer Steps

     

 Eliminate manual specimen transfer steps

 

 FLOQSwab® for NP and mid-turbinate collection

     

 Reduce potential for human error

 

 Inactivates common respiratory viruses

     

 Remove costs for additional consumables

 

 Guanidine free, non-toxic media

 


FLOQSwab® is a registered trademark of COPAN Diagnostics
* The Aptima SARS-CoV-2 and Aptima SARS-CoV-2/Flu assays have not been FDA cleared or approved; These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima SARS-CoV-2 assay has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay  has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, Flu A and Flu B and not for any other viruses or pathogens. The Aptima SARS-CoV-2 and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. 

 

Want Image Slider on Tab Click
no